Stock Forecast

  Plant Advanced Technologies SA ( ALPAT.PA) Stock. Should you Buy or Sell?    $ 16.95

0.10 (0.59 %)



Plant Advanced Technologies SA Analysis

Updated on 03-07-2022
Symbol ALPAT.PA
Price $16.95
Beta 0.890
Volume Avg. $349
Market Cap $18.39 M
52 Week Range $15.05 - $22.2


Plant Advanced Technologies SA opened the day at $16.95 which is +'0.59 % on yesterday's close. Plant Advanced Technologies SA has a 52 week high of $22.2 and 52 week low of $15.05, which is a difference of $7.15. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $18.39 M and total net profit is $1537985 which means the company is trading at 11.96 times profit to market capitalization. Theoretically, if you were to buy Plant Advanced Technologies SA for $18.39 M, it would take 15 years to get your money back. Plant Advanced Technologies SA are in the Biotechnology space which will have a sweet spot and industry standard for net profit multiples.



Price Chart


1 D | All


Financials




Plant Advanced Technologies SA Stock Forecast - Is Plant Advanced Technologies SA a Buy or Sell?


DCF ScoreStrong Buy
ROE ScoreNeutral
ROA ScoreNeutral
DE ScoreBuy
PE ScoreStrong Sell
PB ScoreStrong Buy
Overall RecommendationBuy

Growth and Value


PE Ratio -87.734
Dividend Yiel 0.000
Net Profit Margin -0.163


Valuing Plant Advanced Technologies SA


Price Book Value Ratio 1.967 Price To Book Ratio 1.967
Price To Sales Ratio 14.292 Price Earnings Ratio -87.734


How liquid is Plant Advanced Technologies SA


Current Ratio 2.401
Quick Ratio 0.249


Debt


Debt Ratio 0.431 Debt Equity Ratio 0.758
Long Term Debt To Capitalization 0.356 Total Debt To Capitalization 0.000



Latest news about Plant Advanced Technologies SA






About Plant Advanced Technologies SA


CEO : Jean-Paul Fevre
Sector : Healthcare
Industry : Biotechnology

Website : https://www.plantadvanced.com

Exchange : Paris

Description :

Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include PAT Plant Milking that produces active extracts through plant stimulation and living-root exudation while preserving plants; PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes; and PAT Friday, a recombinant protein expression system using natural protein excretion system of genetically modified carnivorous plants to produce outside their leaf in a sterile closed pitcher. The company was founded in 2005 and is headquartered in Vandœuvre-lès-Nancy, France.


My Newsletter

Sign Up For Updates & Newsletters